These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9012450)

  • 21. Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis.
    Weeks BH; He W; Olson KL; Wang XJ
    Cancer Res; 2001 Oct; 61(20):7435-43. PubMed ID: 11606377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with TGF-beta antisense oligonucleotide-modified autologous tumor vaccine enhances the antitumor immunity of MBT-2 tumor-bearing mice through upregulation of MHC class I and Fas expressions.
    Tzai TS; Shiau AL; Liu LL; Wu CL
    Anticancer Res; 2000; 20(3A):1557-62. PubMed ID: 10928070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy.
    Won J; Kim H; Park EJ; Hong Y; Kim SJ; Yun Y
    Cancer Res; 1999 Mar; 59(6):1273-7. PubMed ID: 10096559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
    Amundadottir LT; Nass SJ; Berchem GJ; Johnson MD; Dickson RB
    Oncogene; 1996 Aug; 13(4):757-65. PubMed ID: 8761297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of suppression of TGF-beta1 expression on cell-cycle and gene expression of beta-1,4-galactosyltransferase 1 in human hepatocarcinoma cells.
    Zhang SW; Lin WS; Ying XL; Zhu D; Guo MY; Gu JX
    Biochem Biophys Res Commun; 2000 Jul; 273(3):833-8. PubMed ID: 10891333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
    Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
    Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
    Okamoto M; Oyasu R
    Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
    Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
    BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells.
    Chang HL; Gillett N; Figari I; Lopez AR; Palladino MA; Derynck R
    Cancer Res; 1993 Sep; 53(18):4391-8. PubMed ID: 8364935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Latent TGF-beta1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis.
    Murano M; Xiong X; Murano N; Salzer JL; Lafaille JJ; Tsiagbe VK
    J Leukoc Biol; 2006 Jan; 79(1):140-6. PubMed ID: 16244108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
    Gorska AE; Joseph H; Derynck R; Moses HL; Serra R
    Cell Growth Differ; 1998 Mar; 9(3):229-38. PubMed ID: 9543389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis.
    Uchio K; Graham M; Dean NM; Rosenbaum J; Desmoulière A
    Wound Repair Regen; 2004; 12(1):60-6. PubMed ID: 14974966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A
    Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor apoptotic bodies inhibit CTL responses and antitumor immunity via membrane-bound transforming growth factor-beta1 inducing CD8+ T-cell anergy and CD4+ Tr1 cell responses.
    Xie Y; Bai O; Yuan J; Chibbar R; Slattery K; Wei Y; Deng Y; Xiang J
    Cancer Res; 2009 Oct; 69(19):7756-66. PubMed ID: 19789353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of tumor metastasis by blockade of transforming growth factor beta signaling in bone marrow cells through a retroviral-mediated gene therapy in mice.
    Shah AH; Tabayoyong WB; Kundu SD; Kim SJ; Van Parijs L; Liu VC; Kwon E; Greenberg NM; Lee C
    Cancer Res; 2002 Dec; 62(24):7135-8. PubMed ID: 12499244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
    Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
    Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of expression of transforming growth factor-beta type II receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, Renca.
    Kundu SD; Kim IY; Zelner D; Janulis L; Goodwin S; Engel JD; Lee C
    J Urol; 1998 Nov; 160(5):1883-8. PubMed ID: 9783979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antisense TGF-beta 1 transfection decreases acute and chronic rejection in allografts].
    Redaelli CA; Schilling MK; Hullett DA; Büchler MW; Sollinger HW
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):699-704. PubMed ID: 14518344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.